Coherus Oncology (CHRS) Shares Issued (2016 - 2024)
Historic Shares Issued for Coherus Oncology (CHRS) over the last 11 years, with Q4 2024 value amounting to $241000.0.
- Coherus Oncology's Shares Issued fell 4894.07% to $241000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$581000.0, marking a year-over-year decrease of 15021.61%. This contributed to the annual value of $926000.0 for FY2024, which is 4881.15% down from last year.
- Per Coherus Oncology's latest filing, its Shares Issued stood at $241000.0 for Q4 2024, which was down 4894.07% from -$822000.0 recorded in Q2 2024.
- In the past 5 years, Coherus Oncology's Shares Issued registered a high of $36.6 million during Q2 2021, and its lowest value of -$30.5 million during Q4 2021.
- Moreover, its 5-year median value for Shares Issued was $1.2 million (2022), whereas its average is $2.1 million.
- Per our database at Business Quant, Coherus Oncology's Shares Issued crashed by 79107.39% in 2021 and then surged by 136310.68% in 2024.
- Coherus Oncology's Shares Issued (Quarter) stood at $4.4 million in 2020, then crashed by 791.07% to -$30.5 million in 2021, then skyrocketed by 102.18% to $665000.0 in 2022, then dropped by 29.02% to $472000.0 in 2023, then tumbled by 48.94% to $241000.0 in 2024.
- Its Shares Issued was $241000.0 in Q4 2024, compared to -$822000.0 in Q2 2024 and $1.5 million in Q1 2024.